Health Services Research & Development

To understand the real-world survival status of patients with different ypTNM stages, we conducted the equivalent stage comparisons between cohort 2 and cohort 1. The DFS of ypI was poorer than that of pI. There was no significant difference in survival between ypI/II and pII. The DFS of ypIII was better than that of pIII. ................
................

In order to avoid copyright disputes, this page is only a partial summary.